Reviews
Systematic reviews
Search a topic, title, author or review id. The Findings tab shows what the reviews found for the same words, grouped by question; the Studies tab shows the primary studies they include.
10 reviews, newest first
Long‐acting muscarinic antagonist (LAMA) plus long‐acting beta‐agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease
Cochraneheadline outcomes only
7 findings
Means restriction for the prevention of suicide by jumping
Cochraneheadline outcomes only
25 findings
Glucose targets for preventing diabetic kidney disease and its progression
Cochraneheadline outcomes only
8 findings
Risk of endometrial cancer in women treated with ovary‐stimulating drugs for subfertility
Cochraneheadline outcomes only
9 findings
Long‐acting muscarinic antagonists (LAMA) added to combination long‐acting beta₂‐agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma
Cochraneheadline outcomes only
7 findings
Routes of administration of antibiotic prophylaxis for preventing infection after caesarean section
Cochraneheadline outcomes only
7 findings
Corticosteroids including ACTH for childhood epilepsy other than epileptic spasms
Cochraneheadline outcomes only
1 finding
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma
Cochraneheadline outcomes only
7 findings
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma
Cochraneheadline outcomes only
7 findings
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long‐acting beta₂‐agonists (LABA) for adults with asthma
Cochraneheadline outcomes only
7 findings